Cisplatin vs Paclitaxel for Triple Negative Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Erica Mayer, MD
Dana-Farber Cancer Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama
Birmingham, Alabama, United States
- Indiana University- Simon Cancer Center
Indianapolis, Indiana, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- South Shore Hospital
Weymouth, Massachusetts, United States
- Memorial Sloan Kettering Cancer Center-Basking Ridge
Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Cancer Center-Monmouth
Middletown, New Jersey, United States
- Memorial Sloan Kettering Cancer Center-Commack
Commack, New York, United States
- Memorial Sloan Kettering Cancer Center-West Harrison
Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Memorial Sloan Kettering Cancer Center-Rockville Centre
Rockville Centre, New York, United States
- Memorial Sloan Kettering Cancer Center-Sleepy Hollow
Sleepy Hollow, New York, United States
- University of North Carolina- Lineberger Cancer Center
Chapel Hill, North Carolina, United States
- Duke University
Durham, North Carolina, United States
- Universtiy of Pittsburgh- Magee-Womens Hospital
Pittsburgh, Pennsylvania, United States
- Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
- Baylor College of Medicine
Houston, Texas, United States
- Seattle Cancer Alliance at Evergreenhealth
Kirkland, Washington, United States
- University of Washignton
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2014
- Primary completion
- 31 Jan 2019
- Completion
- 31 Aug 2020
- Last update posted
- 30 Sept 2025
- Registered enrollment
- 147
- Registry id
- NCT01982448
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.